Study analysis · Molecular Pharmacology · 2007
Broccoli might be sabotaging your meds — here's how.
A chemical in broccoli blocks a liver switch that turns on drug-cleaning enzymes, which could change how your medicines work.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study found that a chemical in broccoli can block a specific protein in liver cells in a test tube. It doesn't show that eating broccoli changes how drugs work in people — just what might happen in a lab dish.
What’s the bottom line?
A chemical in broccoli called sulforaphane sticks to a protein in the liver that normally turns on drug-cleaning enzymes, and stops it from working.
How strong is this study?
We don't know how well the experiment was done because the full details aren't here. It's like seeing a photo of a science project but not knowing if the kid used the right tools or counted correctly — so we can't trust it to tell us real-world answers.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
0 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
0 / 100
- P-valuesno p-values reported
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 520 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
This design cannot establish causation — the findings describe an association, not a cause. Study design cannot be determined from abstract; no explicit mention of randomization, control group, or blinding. In vitro study with no human trial data provided.
Key takeaways
- 01
Sulforaphane blocked the SXR protein from turning on CYP3A4, a key enzyme that breaks down drugs, and reduced drug clearance in human liver cells.
- 02
Yes — if this happens in people, eating broccoli might change how drugs work in the body, possibly preventing some drug interactions.
Surprising findings
- Sulforaphane down-regulates CYP3A4 instead of up-regulating it, despite being known for activating antioxidant pathways.Prior research focused on sulforaphane boosting detox enzymes via Nrf2 — this shows it does the opposite for a major drug-metabolizing enzyme, which contradicts the assumption that it universally enhances detox.
Practical takeaways
If you take prescription drugs metabolized by CYP3A4 (like statins, blood thinners, or anti-anxiety meds), avoid high-dose broccoli supplements.
This study was done in isolated liver cells — real-world effects in humans are unknown. Regular broccoli consumption is unlikely to cause issues.
low confidenceWhy this study matters
Broccoli vs. Your Medicines
Sulforaphane, a compound in broccoli, binds directly to the SXR/hPXR receptor in human liver cells and blocks it from activating CYP3A4 — an enzyme that breaks down over 50% of all prescription drugs. This led to reduced midazolam clearance in the study.
If this happens in people, eating broccoli or taking broccoli supplements could make drugs like statins, blood thinners, or antidepressants work too well — or not at all — raising risks of side effects or treatment failure.
First Natural Drug Blocker Ever Found
This study identifies sulforaphane as the first naturally occurring antagonist of SXR/hPXR — a receptor that normally senses toxins and turns on drug-metabolizing genes.
Most natural compounds activate detox pathways — this one shuts them down. It flips the script on the idea that 'natural = always good for detox.'
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
A chemical in broccoli called sulforaphane sticks to a protein in the liver that normally turns on drug-cleaning enzymes, and stops it from working.
Research results
Sulforaphane blocked the SXR protein from turning on CYP3A4, a key enzyme that breaks down drugs, and reduced drug clearance in human liver cells.
What this means - more context
Yes — if this happens in people, eating broccoli might change how drugs work in the body, possibly preventing some drug interactions.
To determine whether sulforaphane, a compound in broccoli, acts as an antagonist of the human steroid and xenobiotic receptor (SXR/hPXR) and thereby inhibits CYP3A4 expression.
Sulforaphane binds directly to SXR/hPXR, inhibits coactivator recruitment, and represses SXR-mediated induction of CYP3A4 expression and activity in human primary hepatocytes, making it the first identified naturally occurring antagonist of SXR/hPXR.
Methods Used
Experimental study using human primary hepatocytes; sulforaphane was applied to assess its effects on SXR/hPXR binding, coactivator recruitment, and CYP3A4 expression and activity (midazolam clearance).
Main Finding
Sulforaphane is the first identified naturally occurring antagonist of SXR/hPXR and inhibits SXR-mediated CYP3A4 expression and midazolam clearance in human primary hepatocytes.
Confidence Level
Limited - based on abstract only, full methodology not available
Study Flags
Red Flags
- •Full text not available - methodology details cannot be verified
- •No effect sizes, p-values, or confidence intervals reported in abstract
- •Human hepatocyte study but sample size and controls not specified
Surprising Findings
Sulforaphane down-regulates CYP3A4 instead of up-regulating it, despite being known for activating antioxidant pathways.
Prior research focused on sulforaphane boosting detox enzymes via Nrf2 — this shows it does the opposite for a major drug-metabolizing enzyme, which contradicts the assumption that it universally enhances detox.
Practical Takeaways
If you take prescription drugs metabolized by CYP3A4 (like statins, blood thinners, or anti-anxiety meds), avoid high-dose broccoli supplements.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 520 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Human Case-Control
Subject
Lower probability
on the GRADE evidence scale
This study found that a chemical in broccoli can block a specific protein in liver cells in a test tube. It doesn't show that eating broccoli changes how drugs work in people — just what might happen in a lab dish.
Strengths
- Uses human primary cells (not animal or cell line models)
- Mechanistic detail provided (binding, coactivator inhibition, enzyme activity)
Weaknesses
- Full methodology not available - based on abstract only
- No control group, randomization, or blinding described
- No sample size or statistical analysis reported
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
A chemical in broccoli called sulforaphane sticks to a protein in the liver that normally turns on drug-cleaning enzymes, and stops it from working.
Research results
Sulforaphane blocked the SXR protein from turning on CYP3A4, a key enzyme that breaks down drugs, and reduced drug clearance in human liver cells.
What this means - more context
Yes — if this happens in people, eating broccoli might change how drugs work in the body, possibly preventing some drug interactions.
To determine whether sulforaphane, a compound in broccoli, acts as an antagonist of the human steroid and xenobiotic receptor (SXR/hPXR) and thereby inhibits CYP3A4 expression.
Sulforaphane binds directly to SXR/hPXR, inhibits coactivator recruitment, and represses SXR-mediated induction of CYP3A4 expression and activity in human primary hepatocytes, making it the first identified naturally occurring antagonist of SXR/hPXR.
Methods Used
Experimental study using human primary hepatocytes; sulforaphane was applied to assess its effects on SXR/hPXR binding, coactivator recruitment, and CYP3A4 expression and activity (midazolam clearance).
Main Finding
Sulforaphane is the first identified naturally occurring antagonist of SXR/hPXR and inhibits SXR-mediated CYP3A4 expression and midazolam clearance in human primary hepatocytes.
Confidence Level
Limited - based on abstract only, full methodology not available
Study Flags
Red Flags
- •Full text not available - methodology details cannot be verified
- •No effect sizes, p-values, or confidence intervals reported in abstract
- •Human hepatocyte study but sample size and controls not specified
Surprising Findings
Sulforaphane down-regulates CYP3A4 instead of up-regulating it, despite being known for activating antioxidant pathways.
Prior research focused on sulforaphane boosting detox enzymes via Nrf2 — this shows it does the opposite for a major drug-metabolizing enzyme, which contradicts the assumption that it universally enhances detox.
Practical Takeaways
If you take prescription drugs metabolized by CYP3A4 (like statins, blood thinners, or anti-anxiety meds), avoid high-dose broccoli supplements.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 520 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Human Case-Control
Subject
Lower probability
on the GRADE evidence scale
This study found that a chemical in broccoli can block a specific protein in liver cells in a test tube. It doesn't show that eating broccoli changes how drugs work in people — just what might happen in a lab dish.
Strengths
- Uses human primary cells (not animal or cell line models)
- Mechanistic detail provided (binding, coactivator inhibition, enzyme activity)
Weaknesses
- Full methodology not available - based on abstract only
- No control group, randomization, or blinding described
- No sample size or statistical analysis reported
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
We don't know how well the experiment was done because the full details aren't here. It's like seeing a photo of a science project but not knowing if the kid used the right tools or counted correctly — so we can't trust it to tell us real-world answers.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
0 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
0 / 100
- P-valuesno p-values reported
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 520 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
This design cannot establish causation — the findings describe an association, not a cause. Study design cannot be determined from abstract; no explicit mention of randomization, control group, or blinding. In vitro study with no human trial data provided.
Standing
Who’s using this study?
The videos and claims on this site that lean on this study, and the researchers who wrote it.
1 video from Nutrition Made Simple! cite this study, drawing 1 claim from it.
- Very strong evidence
Randomized or controlled trials support this claim, alongside consistent supporting evidence.
Evidence
Authored by
7 researchersIf this is your work, this is how we attribute it on Fit Body Science. Changcheng Zhou is listed as the lead author.